Purity 99% CAS 2805997-46-8 Top Quality Survodutide Weight Loss Peptide

Cagrilintide is an innovative therapeutic agent with the following details:

English name: Cagrilintide

CAS number: 1415456-99-3

Drug type: belongs to amylin (amylin) receptor agonists, which are long-acting analogues of natural amylin. Natural amylin is secreted by pancreatic β cells, which regulates metabolism in synergy with insulin, and has the effects of suppressing appetite, delaying gastric emptying, and reducing glucose absorption.

As a new type of amylin receptor agonist, Cagrilintide's core value lies in achieving efficient weight loss through its unique mechanism of action. Especially when used in combination with GLP-1 receptor agonists, it is expected to become a new treatment option for obesity. Currently, its research and development are progressing smoothly. If approved in the future, it will provide more treatment choices for patients with metabolic diseases. However, its final indications, dosage regimens, and long-term safety still need to be confirmed by the results of Phase III clinical trials and regulatory approvals.

Cagrilintide exerts multiple metabolic regulatory effects by activating amylin receptors:

Suppressing appetite and reducing food intake: It acts on the central nervous system (such as the hypothalamus) to reduce hunger and decrease food consumption, thereby controlling calorie intake.

Delaying gastric emptying: It slows down the digestion and absorption of food in the gastrointestinal tract, prolonging the duration of satiety.

Regulating blood glucose: It may assist in blood glucose control by reducing hepatic glucose production and enhancing insulin sensitivity (this effect is still under research, and its main advantage remains focused on weight loss).